John William Wulf bought $98k of AGL
director at agilon health, inc.. 45,000 shares at an average of $2.18, traded Dec 5, 2024, filed Dec 11, 2024.
Score components
- +15RoleDirector
- +10Trade size$98k at market
- +6Relative to holdingsHoldings up 28%
- 0Price contextNo price history yet
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-24-050831, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 5, 2024 | POpen-market purchase Common Stock | +45,000 | $2.18 | $98k | 206,133 | Dec 11, 2024 |
Related signals
Other insiders at agilon health, inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 47Moderate | agilon health, inc. | Silvana Battaglia director | $50k 25,062 shares | +61% | |
| 47Moderate | agilon health, inc. | Karen McLoughlin director | $55k 25,000 shares | +52% | |
| 39Weak | agilon health, inc. | Diana McKenzie director | $45k 20,000 shares | +52% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.